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RESEARCH ARTICLE Open Access
Deletion of the NR4A nuclear receptor
NOR1 in hematopoietic stem cells reduces
inflammation but not abdominal aortic
aneurysm formation
Hua Qing1,2,3,4, Karrie L. Jones4, Elizabeth B. Heywood4, Hong Lu2,4,5, Alan Daugherty2,4,5 and Dennis Bruemmer1,2,4*
Abstract
Background: The NR4A3 orphan nuclear hormone receptor, NOR1, functions as a constitutively active transcription
factor to regulate inflammation, proliferation, and cell survival during pathological vascular remodeling. Inflammatory
processes represent key mechanisms leading to abdominal aortic aneurysm (AAA) formation. However, a role of NOR1
in AAA formation has not been investigated previously.
Methods: Inflammatory gene expression was analyzed in bone marrow-derived macrophages isolated from
NOR1-deficient mice. Low-density lipoprotein receptor-deficient (LDLr−/−) mice were irradiated and reconstituted
with hematopoietic stem cells obtained from NOR1−/− or wild-type littermate mice. Animals were infused with
angiotensin II and fed a diet enriched in saturated fat to induce AAA formation. Quantification of AAA formation
was performed by ultrasound and ex vivo measurements.
Results: Among 184 inflammatory genes that were analyzed, 36 genes were differentially regulated in LPS-treated
NOR1-deficient macrophages. Albeit this difference in gene regulation, NOR1-deficiency in hematopoietic stem cells
did not affect development of AAA formation in bone marrow-derived stem cell transplanted LDLr-deficient mice.
Conclusion: NOR1 deletion induced differential inflammatory gene transcription in macrophages but did not influence
AAA formation in mice.
Keywords: Nuclear receptor, Bone marrow transplantation, Aneurysm, Angiotensin II
Background
Abdominal aortic aneurysms (AAA) affect more than 1.1
million people in the United States and bear an 85%
chance of death after rupture [1]. Each year in the
United States, more than 16,000 deaths result from
rupture of abdominal aortic aneurysms, and 33,000 pa-
tients undergo repair of asymptomatic abdominal aortic
aneurysms to prevent future rupture [2]. Albeit the high
morbidity and mortality associated with aneurysm for-
mation, there are no validated or approved medical
therapies for attenuating aneurysm growth and rupture.
With increasing recognition of the devastating impact of
aneurysmal rupture, ongoing research efforts aim to de-
termine mechanisms of initiation and progression of
aneurysms.
Medial infiltration of macrophages and the activation
of inflammatory signaling represents the earliest histo-
logical change during the initiation of AAA formation
[3, 4]. Locally secreted inflammatory signals act on these
infiltrating myeloid cells by inducing signal-stimulated
transcription factors. Among these, the NR4A subgroup
of orphan nuclear receptors represents immediate-early
response genes, which are expressed rapidly in response
to inflammatory stimulation and control essential cellu-
lar functions in all processes of pathological vascular re-
modeling [5, 6]. The NR4A3 subfamily member NOR1
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is highly expressed in human abdominal aortic aneurysm
tissues [7] and has been implicated previously in prolif-
eration of myeloid progenitor cells [8, 9], recruitment of
monocytes to sites of inflammation [10], transcription of
inflammatory gene expression [11, 12], and macro-
phage apoptosis [13]. Based on this key function of
NOR1 in the control of inflammation combined with
the well-established contribution of macrophage-induced
inflammatory signaling to AAA formation [14, 15], we in-
vestigated whether NOR1 deletion affects development of
AAA.
Methods
Cell culture
Bone marrow-derived macrophages (BMDM) were cul-
tured and differentiated as described [16]. Briefly, bone
marrow cells were isolated from femurs of NOR1-
deficient mice and their wild-type littermates [17], and
differentiated in DMEM medium supplemented with
20% fetal bovine serum and 30% L929 cell-conditioned
medium for 10 days. Cells were incubated with 100 ng/ml
lipopolysaccharides (LPS) at the indicated time points be-
fore harvesting total RNA for gene expression analyses.
Gene expression analysis
RNA was isolated and reverse transcribed as described
[9]. Inflammatory gene expression was profiled using
nCounter GX mouse inflammation kit consisting of 184
inflammation-related genes and 6 internal reference
genes and analyzed by nSolver software 2.6 (NanoString
Technologies) as directed by the manufacturer [18]. The
in silico analysis for the NOR1 consensus NBRE (NGFI-
B response element) motif within differentially regulated
genes was performed using the MatInspector software
(Genomatix Inc., Ann Arbor, MI). Real-time RT-PCR
was performed with the iCycler and SYBR Green I system
(Bio-Rad, Hercules, Calif). Each sample was analyzed in
triplicate and normalized to transcription factor IIB (TFIIB)
mRNA expression, and data was calculated using the 2-
ΔΔCt method [19]. Sequences of the primers for RT-PCR
were as follows: NOR1 Forward 5′-GGCCGCAGCTGC
ACTCAGTC -3, Reverse 5′-GCGGAGGGAAGGTCAG
CGTG -3′; TFIIB Forward: 5′-CTCTCCCAAGAGTCAC
ATGTCC-3′, Reverse: 5′-CAATAACTCGGTCCCCTAC
AAC-3′.
Animals
Male wild-type littermate (NOR1+/+) and NOR1-deficient
(NOR1−/−) mice on a mixed C57BL/6 J/129Sv background
were used as described previously [17]. Bone marrow
transplantation was performed by tail vein injection of
bone marrow-derived cells isolated from NOR1-deficient
or wild-type littermate mice to lethally irradiated male
LDLr−/− mice purchased from The Jackson Laboratory
(Stock # 002207; Bar Harbor, ME) as described [16]. Mice
were fed a saturated fat-enriched diet (Harlan Teklad
TD88137) for 5 weeks after bone marrow transplantation.
One week after initiation of diet feeding, angiotensin II
(1000 ng/kg/min) was infused subcutaneously for 4 weeks
using Alzet osmotic minipumps (Alzet Model 2004,
Durect Corp, Cupertino, CA, U.S.A.). All studies were
performed with the approval of the University of Kentucky
Institutional Animal Care and Use Committee.
Systolic blood pressure measurement
Systolic blood pressure was measured on conscious mice
using non-invasive BP-2000 blood pressure system (Visi-
tech Systems, Inc., Apex, NC, U.S.A.) during the last
3 days of angiotensin II infusion as described previously
[20]. This noninvasive tail-cuff system records tail blood
volume changes that correspond to systolic and diastolic
blood pressure [21].
AAA quantification
AAA formation was quantified by measurement of
maximal lumen diameters of suprarenal abdominal aor-
tas. High-frequency ultrasound (Visualsonics) was per-
formed on anesthetized mice to measure suprarenal
abdominal aortic diameters and areas prior to and on
the final day of angiotensin II infusion. Thereafter, aor-
tas were excised at termination, and AAA size was
quantified ex vivo by measuring the aorta dissected
from sacrificed mice with ImagePro Plus software as
described previously [16].
Statistics
To compare two groups on a continuous response vari-
able, we used a Student t test or Mann–Whitney U test
as appropriate. One-way ANOVA was used to compare
multiple groups, followed by Turkey post hoc analysis.
All data are represented as means ± SEM. P values
<0.05 were considered to be statistically significant.
Results
Genetic NOR1 deletion altered inflammatory gene
expression
To first investigate the regulation of NOR1 in macro-
phages, we incubated BMDM isolated from wild-type lit-
termate and NOR1−/− mice with LPS. As depicted in
Fig. 1, stimulation of macrophages induced a robust in-
crease in NOR1 mRNA abundance, which was com-
pletely absent in cells deficient for the NOR1 locus.
Since inducible expression of NOR1 in activated macro-
phages indicated an important function in control of
macrophage inflammation, we next profiled LPS-treated
NOR1−/− macrophages for 184 inflammatory gene tran-
scripts using nCounter Gene Expression Assays. Thirty-
six genes were differentially regulated in response to LPS
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treatment of NOR1-deficient macrophages, compared to
their wild-type control cells (Additional file 1: Table S1).
Among those differentially regulated genes, a large
proportion of transcripts were of cytokine and chemo-
kine family of proteins. Figure 2 depicts those eight
genes that were at least 50% increased or decreased
compared to wildtype cells (Fig. 2a-c). In silico ana-
lyses of promoter sequences further identified that 18
genes contained NBRE consensus sequences within
their promoters, characterizing these as potential
NOR1 target genes (Additional file 2: Table S2).
Bone marrow deletion of NOR1 did not affect angiotensin
II-induced AAA formation
Monocyte recruitment constitutes one of the earliest
events during formation of AAA [3, 4]. Because genetic
NOR1 deletion altered expression of key inflammatory
mediators implicated in monocyte recruitment and their
activation, we next investigated whether NOR1 deletion
affected AAA formation. One of the widely accepted
AAA models includes infusion of angiotensin II into
hyperlipidemic mice [20], which induces abdominal
aneurysm development with a high degree of rupture
and resembles many aspects of human pathology [22].
To generate AAA formation in mice with NOR1 dele-
tion in macrophages, we performed transplantation with
bone marrow-derived cells and reconstituted LDLr-
deficient mice with either wild-type or NOR1-deficient
hematopoietic stem cells. Following reconstitution, mice
were fed a saturated fat-enriched diet and infused with
angiotensin II using the protocol depicted in Fig. 3.
Angiotensin II has well characterized effects to in-
crease blood pressure, although its vascular activity to
promote AAA formation are largely independent of this
vasopressor function [23]. To assess whether deficiency
of the NOR1 locus in hematopoietic cells affected blood
pressure, we first performed tail-cuff analyses for blood
pressure measurements. As shown in Fig. 4, angiotensin
II infusion induced a comparable increase in systolic
blood pressure in recipient mice engrafted with either
wild-type or NOR1-deficient bone marrow 4 weeks after
angiotensin II perfusion (Fig. 4). Suprarenal abdominal
aortic lumen diameters and areas were quantified in vivo
by ultrasound and ex vivo using morphometric analysis.
However, recipient LDLr−/− mice with NOR1 deletion in
bone marrow-derived cells showed no difference in
AAA size compared to LDLr−/− mice reconstituted with
wild-type bone marrow (Fig. 5a-c). Therefore, genetic
NOR1 deletion in hematopoietic stem cell has no overt
effect on formation of angiotensin II-induced AAA.
Discussion
NOR1 expression in macrophages regulates proliferation
[8, 9], inflammation [11, 12], macrophage lipid-uptake
[12], and apoptosis [13]. While these cellular functions
have been implicated in initiation of AAA formation
[24], it remains currently unknown whether NOR1 con-
tributes to their formation. Therefore, we depleted mac-
rophages of NOR1 using bone marrow transplantation
and analyzed whether macrophage NOR1 function af-
fected AAA development in chimeric mice. Although
deletion of the NOR1 locus attenuated expression of
multiple inflammatory genes, NOR1 deficiency in wall-
infiltrating cells derived from hematopoietic progenitors
did not affect the initiation of angiotensin II-induced
AAA formation.
NOR1 is expressed in all cell types of the vascular wall,
including endothelial cells, smooth muscle cells, and in-
filtrating macrophages [5]. While basal levels of expres-
sion are low, NOR1 is induced rapidly in response to
mitogenic and inflammatory signaling underlying patho-
logical vascular remodeling [5]. Macrophage activation
represents a major mechanism of vascular disease initi-
ation, as inhibition of their infiltration and inflammatory
signaling prevents all major vascular diseases, including
atherosclerosis and AAA formation [25, 26]. Several
prior studies have identified a key role of inducible
NOR1 expression in the regulation of macrophage func-
tion, including activation of pro-inflammatory [11] but
also anti-inflammatory gene regulation [12, 27]. In con-
trast to these previous studies using viral NOR1 overex-
pression, our inflammation-biased profiling experiments
employed loss-of-function using cells isolated from mice
harboring genetic deletion of the NOR1 locus. While dif-
ferent in approach, we observed that 36 out of the 184
Fig. 1 NOR1 expression in wild-type and NOR1-deficient BMDM. BMDM
were isolated from NOR1-deficient mice and littermate wild-type control
mice. Cells were incubated with 100 ng/ml LPS, and mRNA was
harvested at the indicated time points. NOR1 mRNA expression
was analyzed by real-time RT-PCR. Data were normalized to
transcript abundance of the housekeeping gene TFIIB and presented as
fold increase relative to control cells. Values are mean ± SEM (* P < 0.05
vs. control cells, n = 3 mice/group)
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Fig. 2 Genetic NOR1 Deletion Impaired Inflammatory Gene Expression. BMDM isolated from NOR1+/+ or NOR1−/− mice (n = 6 mice per group)
were incubated with 100 ng/ml LPS for 8 h before harvesting RNA for nCounter gene expression profiling. RNA from two mice of the same strain
were pooled together and analyzed for transcript expression. a-c. Histograms of genes which revealed more than 50% difference in transcript
abundance in response to LPS-stimulation of NOR1+/+ and NOR1−/− BMDM. Data was processed using the nSolver software and presented as
fold increase relative to untreated BMDM of the same genotype. Values are mean ± SEM (* P < 0.05 vs. NOR1+/+)
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analyzed inflammatory genes were differentially expressed,
although the magnitude of significant differences was
overall mild. Among those regulated genes, the majority
were pro-inflammatory, and their expression was de-
creased in NOR1-deficient cells, including for example IL-
6 and TNFα. These loss-of-function studies are consistent
with the observations of Pei et al. that NOR1 expression
induces transcription of inflammatory genes and activates
NF-κB-dependent gene regulation in macrophages [11].
Furthermore, several of the differentially regulated genes
revealed putative NBRE binding sites for NOR1, suggest-
ing potentially direct mechanisms of gene regulation.
However, in addition to direct gene regulation, NOR1 de-
letion induces the Ly6-C(hi) monocyte population [8, 9]
and is likely to affect myeloid lineage specification, which
may further alter inflammatory signaling, particularly in
vivo.
Considering the literature supporting an important
function of NOR1 in macrophage gene regulation
[11, 12, 27], combined with our own observations
Fig. 3 Experimental Design and AAA Formation Study Protocol. LDLr-deficient mice were reconstituted with bone marrow-derived cells from either
NOR1+/+ or NOR1−/− mice. Four weeks after engraftment, a diet enriched in saturated fat was fed to transplanted mice beginning one week prior to
the start of angiotensin II infusion. The body weight was measured every week; AAA formation was evaluated by ultrasound before and after angiotensin
II infusion; blood pressures were measured on three consecutive days before the termination of angiotensin II infusion using a non-invasive blood
pressure system
Fig. 4 Systolic blood pressure after 28-day angiotensin II infusion in chimeric LDLr−/− mice with macrophage deletion of NOR1. Systolic blood
pressure (SBP) was measured on three consecutive days before the termination of angiotensin II infusion using a noninvasive tail-cuff system recording
the tail blood volume changes that correspond to systolic and diastolic blood pressure. Filled circles (NOR1+/+ donors, n = 13) and open circles
(NOR1−/− donors, n = 11) represent measurements in individual mice; diamonds represent the average for each group, and bars indicate SEM
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discussed above, and further that infiltration of circu-
lating monocytes represents one of the earliest mech-
anisms of AAA formation [4], we tested whether
NOR1 deletion in bone marrow-derived cells affected
AAA formation and progression. Activation of the
renin-angiotensin system constitutes a key mechan-
ism of AAA formation, and infusion of angiotensin II
induces AAA formation in hyperlipidemic mice [20],
which closely resembles many aspects of human
pathology [22]. Unexpectedly, bone marrow cell dele-
tion of NOR1 did not affect formation or rupture in-
cidence of AAA. Since infiltrating macrophages
during AAA formation are primarily derived from
the bone marrow [28], NOR1 expression in these
cells appeared not to be a major determinant of
AAA formation, albeit the noted differential gene ex-
pression seen in NOR1-deficient macrophages.
There are several potential explanations for these
seemingly discrepant observations. First, it is possible
that those genes that were regulated by NOR1 are either
not causally involved in AAA or that the magnitude of
regulation by NOR1 is insufficient to affect the disease
development. However, in our in vitro studies, IL-6 ex-
pression, for example, was decreased in NOR1-deficient
macrophages, and inhibition of IL-6 has been demon-
strated to prevent angiotensin II-induced aneurysm for-
mation [29]. Second, it is more likely that there is a
balance between the regulation of pro- and anti-
inflammatory genes by NOR1, and that the overall net
effect on macrophage function does not modulate the
initiation and severity of AAA formation. That this hy-
pothesis could be conceivable is supported by the observa-
tion that IL-4, which polarizes macrophages towards the
more anti-inflammatory M2 phenotype, was increased in
NOR1-deficient cells. Third, potential anti-inflammatory
effects of NOR1 deletion within locally infiltrating macro-
phages may become mitigated by an increased number of
circulating monocytes. NR4A nuclear receptors have been
identified previously as tumor suppressors for myeloid
lineage, and deletion of NOR1 increases the Ly6-C(hi)
monocyte population [8, 9]. Therefore, NOR1 deficiency
specifically in the hematopoietic lineage may increase the
number of pro-inflammatory monocytes in the circula-
tion, which could compensate for decreased inflammatory
gene expression and ultimately increase AAA formation
[28]. Finally, it is possible, if not likely, that decreased in-
flammation of infiltrating NOR1-deficient macrophages
during angiotensin II-induced vascular remodeling may be
compensated by an increase in inflammatory gene expres-
sion or matrix remodeling enzymes in resident endothelial
and vascular smooth muscle cells. Although we have not
performed an extensive histological examination of tis-
sues, this notion is supported by the recent findings that
expression of NOR1 in endothelial cells increased mono-
cyte adhesion through the regulation of VCAM-1 and
ICAM-1 [30], which constitutes an important early mech-
anism of AAA formation [31]. However, dissecting the
more cell-specific contribution of NOR1 in endothelial
cells, smooth muscle cells, and mature macrophages will
depend on genetic deletion using conditional, cell-specific
gene targeting in future experiments.
Conclusion
In conclusion, our data demonstrate that genetic NOR1
deletion induces moderate effects on macrophage in-
flammatory gene expression but does not affect angio-
tensin II-induced AAA formation.
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